Schaffhausen, 03/06/24 – Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to announce its acquisition of AllergyCare AG, a Swiss distribution company of pharmaceutical and consumer health products with a focus on the prevention and treatment of allergies. As part of a succession solution, the Ewopharma Group was able to acquire AllergyCare AG retroactively from 1st January 2024. Ewopharma and AllergyCare AG enjoyed several specific points of contact through the same brand they represent. For the last decades, Ewopharma Group has successfully grown its business and continued its geographic expansion. The acquisition opens new expertise for Ewopharma to explore the Swiss home market, this with AllergyCare’s existing staff and partnerships. Mr. Alain Staub, CEO of the Ewopharma Group, commented, “This is another significant step for the Ewopharma Group to have a dedicated sales and marketing team in place and to enable Ewopharma to unlock the potential of the Swiss pharmaceutical market. The experienced team at AllergyCare AG, headed by Bruna Ofner and Aida Skopljak, will be instrumental in the company’s continued business growth. We are convinced that this acquisition will strengthen our position and create additional jobs.” AllergyCare AG is a perfect fit for Ewopharma as both companies share the same appreciation for our most important asset, our employees, and strive to deliver high quality products and information to our customers. Joint synergies will make AllergyCare AG and Ewopharma more effective and ensure further growth. Contact: pr@ewopharma.com
